These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Matrix metalloproteinases. Vargová V; Pytliak M; Mechírová V Exp Suppl; 2012; 103():1-33. PubMed ID: 22642188 [TBL] [Abstract][Full Text] [Related]
66. Dysregulation of metalloproteinases in spinal ligament degeneration. Wang C; Wei Z; Yu T; Zhang L Connect Tissue Res; 2023 Jul; 64(4):310-322. PubMed ID: 36600486 [TBL] [Abstract][Full Text] [Related]
67. Extracellular matrix roles during cardiac repair. Jourdan-Lesaux C; Zhang J; Lindsey ML Life Sci; 2010 Sep; 87(13-14):391-400. PubMed ID: 20670633 [TBL] [Abstract][Full Text] [Related]
68. The cell surface: the stage for matrix metalloproteinase regulation of migration. Seiki M Curr Opin Cell Biol; 2002 Oct; 14(5):624-32. PubMed ID: 12231359 [TBL] [Abstract][Full Text] [Related]
69. Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases. Spinale FG Circ Res; 2002 Dec; 91(12):1082-4. PubMed ID: 12480806 [No Abstract] [Full Text] [Related]
70. Cardiac remodeling induced by smoking: concepts, relevance, and potential mechanisms. Minicucci MF; Azevedo PS; Polegato BF; Paiva SA; Zornoff LA Inflamm Allergy Drug Targets; 2012 Dec; 11(6):442-7. PubMed ID: 22680625 [TBL] [Abstract][Full Text] [Related]
71. New Insights into the Role of Basement Membrane-Derived Matricryptins in the Heart. Okada M; Imoto K; Sugiyama A; Yasuda J; Yamawaki H Biol Pharm Bull; 2017; 40(12):2050-2060. PubMed ID: 29199230 [TBL] [Abstract][Full Text] [Related]
72. Integrins, adhesion, and cardiac remodeling. Hsueh WA; Law RE; Do YS Hypertension; 1998 Jan; 31(1 Pt 2):176-80. PubMed ID: 9453299 [TBL] [Abstract][Full Text] [Related]
73. A fresh prospect of extracellular matrix hydrolytic enzymes and their substrates. Roycik MD; Fang X; Sang QX Curr Pharm Des; 2009; 15(12):1295-308. PubMed ID: 19355969 [TBL] [Abstract][Full Text] [Related]
74. Extracellular matrix dynamics in vascular remodeling. Ma Z; Mao C; Jia Y; Fu Y; Kong W Am J Physiol Cell Physiol; 2020 Sep; 319(3):C481-C499. PubMed ID: 32579472 [TBL] [Abstract][Full Text] [Related]
75. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes. Bhalla V; Georgiopoulou VV; Azeem AA; Marti CN; Cole RT; Laskar SR; De Staercke C; Hooper WC; Smith AL; Kalogeropoulos AP; Butler J Int J Cardiol; 2011 Sep; 151(2):237-9. PubMed ID: 21723628 [No Abstract] [Full Text] [Related]
76. Contributory role of matrix metalloproteinases in cardiovascular remodeling. Gunasinghe SK; Ikonomidis J; Spinale FG Curr Drug Targets Cardiovasc Haematol Disord; 2001 Dec; 1(2):75-91. PubMed ID: 12769658 [TBL] [Abstract][Full Text] [Related]
77. Towards integrating extracellular matrix and immunological pathways. Boyd DF; Thomas PG Cytokine; 2017 Oct; 98():79-86. PubMed ID: 28325629 [TBL] [Abstract][Full Text] [Related]
78. Integrins, focal adhesions, and cardiac fibroblasts. Manso AM; Kang SM; Ross RS J Investig Med; 2009 Dec; 57(8):856-60. PubMed ID: 19952893 [TBL] [Abstract][Full Text] [Related]
79. Intramuscular extracellular matrix: complex environment of muscle cells. Kovanen V Exerc Sport Sci Rev; 2002 Jan; 30(1):20-5. PubMed ID: 11800495 [TBL] [Abstract][Full Text] [Related]
80. RETRACTED: Effect of phentolamine on myocardial extracellular matrix of cardiac remodeling in rats. Yin YG; Wang RZ; Ruan ZB; Zhu L Asian Pac J Trop Med; 2014 Aug; 7(8):645-649. PubMed ID: 25149379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]